FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BARCLAYS PLC
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/9/2021 

3. Issuer Name and Ticker or Trading Symbol

Future Health ESG Corp. [FHLTU]
(Last)        (First)        (Middle)

1 CHURCHILL PLACE, CANARY WHARF
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

LONDON, X0 E14 5HP      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Class A Ordinary Share, par value $0.0001 per share 3512288 (1)I By Barclays Bank PLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Redeemable Warrants  (2) (2)Class A Ordinary Share 1756144 $11.5 I By Barclays Bank PLC 

Explanation of Responses:
(1) Beneficially owned Class A ordinary shares and redeemable warrants are comprised in Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
(2) The redeemable warrants will become exercisable on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the initial public offering of the issuer's securities. The redeemable warrants will expire five years after the completion of the issuers initial business combination or earlier upon redemption by or liquidation of the issuer, as described in the prospectus for the issuer's initial public offering.

Remarks:
Name of person filing:
Barclays PLC
Barclays Bank PLC (controlled by Barclays PLC)

Address of Principal Business Office or, if none, Residence:
Barclays PLC
1 Churchill Place
London, E14, 5HP, England

Barclays Bank PLC
1 Churchill Place
London, E14, 5HP, England

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
BARCLAYS PLC
1 CHURCHILL PLACE
CANARY WHARF
LONDON, X0 E14 5HP

X


Signatures
Suejean Mott12/13/2021
**Signature of Reporting PersonDate

Future Health ESG (NASDAQ:FHLT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Future Health ESG 차트를 더 보려면 여기를 클릭.
Future Health ESG (NASDAQ:FHLT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Future Health ESG 차트를 더 보려면 여기를 클릭.